JAAD 03/26 Disability and the Dermatology Patient - Part 1: Improving Access to Dermatologic Care

JAAD 03/26 Disability and the Dermatology Patient – Part 2: Supporting Patients with Disabilities

Patients with disabilities make up a significant share of dermatology practices, yet many clinicians receive little training on how to best serve them. This CME activity covers how to make dermatologic care more accessible for patients with cognitive, motor, visual, and hearing disabilities, then turns to dermatologic conditions that can themselves cause disability, including how to identify, document, and support patients through the disability process. Learn practical strategies to deliver more accessible, patient-centered care.

1 CME

JAAD 02/26 Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Molecular Profile, Clinical Presentation, and Diagnosis

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME

JAAD 02/26 Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME

JAAD 01/26 Augmented Intelligence and Dermatology - Part I: Core Concept and Applications

AI is transforming dermatology, but are you ready to use it wisely? This CME activity breaks down the essentials, from how AI models are built to where bias, ethics, and regulation come into play. Learn to speak the language of AI and critically evaluate the tools shaping the future of skin care.

1 CME

JAAD 12/25 Lentigo Maligna Part I: Epidemiology, Risk Factors, and Diagnosis

Multiple Credits

JAAD 04/26 Frontal Fibrosing Alopecia (FFA) Part I - Diagnosis and Clinical Presentation

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME

JAAD 12/25 Lentigo Maligna Part II: Management

Multiple Credits

JAAD 01/26 Augmented Intelligence and Dermatology - Part II: Bias, Benchmarks, Guidelines, Ethics, Regulation, and Future Directions

AI is transforming dermatology, but are you ready to use it wisely? This CME activity breaks down the essentials, from how AI models are built to where bias, ethics, and regulation come into play. Learn to speak the language of AI and critically evaluate the tools shaping the future of skin care.

1 CME

JAAD 04/26 Frontal Fibrosing Alopecia Part II: Etiopathogenesis and Management

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME

JAAD 11/25 Hand Eczema. Part 1: Epidemiology, pathogenesis, diagnosis and work-up

Multiple Credits